M&A Deal Summary

Affymetrix Acquires Eureka Genomics

On May 14, 2015, Affymetrix acquired information technology company Eureka Genomics for 15M USD

Acquisition Highlights
  • This is Affymetrix’s 1st transaction in the Information Technology sector.
  • This is Affymetrix’s 5th largest (disclosed) transaction.
  • This is Affymetrix’s 7th transaction in the United States.
  • This is Affymetrix’s 1st transaction in Texas.

M&A Deal Summary

Date 2015-05-14
Target Eureka Genomics
Sector Information Technology
Buyer(s) Affymetrix
Deal Type Add-on Acquisition
Deal Value 15M USD

Target

Eureka Genomics

Houston, Texas, United States
Eureka Genomics Corp. is a developer of cost-effective, low- to mid-plex, high throughput genotyping assays that use common next-generation sequencing (NGS) platforms for signal readout.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Affymetrix

Santa Clara, California, United States

Category Company
Founded 1991
Sector Medical Products
Employees1,200
Revenue 349M USD (2014)
DESCRIPTION

Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.


DEAL STATS #
Overall 7 of 7
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 7 of 7
State: Texas M&A 1 of 1
Country: United States M&A 7 of 7
Year: 2015 M&A 1 of 1
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-14 Anatrace

Maumee, Ohio, United States

Anatrace is a developer, manufacturer and distributor of unique, high purity detergents and synthetic lipids for use in membrane protein studies. Anatrace is based in Maumee, Ohio.

Sell -